Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF), a progressive life-limiting lung disease affects approximately 128 000 newly diagnosed individuals in the USA annually. IPF, a disease of ageing associated with intense medical and financial burden, is expected to grow in incidence globally. Median...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindell, Kathleen Oare, Nouraie, Mehdi, Klesen, Melinda J, Klein, Sara, Gibson, Kevin F, Kass, Daniel J, Rosenzweig, Margaret Quinn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844378/
https://www.ncbi.nlm.nih.gov/pubmed/29531748
http://dx.doi.org/10.1136/bmjresp-2017-000272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844378/
https://www.ncbi.nlm.nih.gov/pubmed/29531748
http://dx.doi.org/10.1136/bmjresp-2017-000272

Ejemplares similares